Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.